Skip to main content
logo
DNA X, Inc. (SONM)
NASDAQ: SONM · Real-Time Price · USD
4.490
+0.250 (5.90%)
May 29, 2026, 10:34 AM EDT - Market open

DNA X Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---93.6369.8354.57
Revenue Growth (YoY)
---34.09%27.96%-14.72%
Cost of Revenue
---74.3158.2148.16
Gross Profit
---19.3211.626.41
Selling, General & Admin
-5.413.117.0417.9419.85
Research & Development
---1.777.9717.7
Other Operating Expenses
-----6.87
Total Operating Expenses
05.413.118.8125.9144.42
Operating Income
--5.41-3.10.51-14.29-38
Interest Income
0.05-----
Interest Expense
-1.53-1.49-0.03-0.02-0.1-
Other Non-Operating Income (Expense)
-0.6-1.060.25-0.210.48-0.46
Total Non-Operating Income (Expense)
-2.08-2.550.22-0.230.39-0.46
Pretax Income
-15.93-7.96-2.880.28-13.9-38.46
Provision for Income Taxes
0.23--0.370.180.17
Net Income
-14.78-20.66-33.65-0.09-14.09-38.63
Earnings From Discontinued Operations
10.27-12.7-30.77---
Net Income to Common
-14.78-20.66-33.65-0.09-14.09-38.63
Shares Outstanding (Basic)
110000
Shares Outstanding (Diluted)
110000
Shares Change (YoY)
239.56%175.71%10.04%48.42%2952.34%104.82%
EPS (Basic)
-23.48-28.58-128.37-0.36-88.20-7344.00
EPS (Diluted)
-23.48-28.58-128.37-0.36-88.20-7344.00
Shares Outstanding
1.271.270.280.250.230.1
Free Cash Flow
-17.39-23.53-8.7-4.09-12.37-38.52
Free Cash Flow Per Share
-18.19-32.55-33.19-17.16-77.06-7326.24
Gross Margin
---20.64%16.65%11.75%
Operating Margin
---0.55%-20.46%-69.64%
Profit Margin
----0.10%-20.17%-70.78%
FCF Margin
----4.37%-17.71%-70.59%
EBITDA
3.25-1.110.462.72-11.92-35.87
EBITDA Margin
---2.90%-17.06%-65.74%
EBIT
--5.41-3.10.51-14.29-38
EBIT Margin
---0.55%-20.46%-69.64%
Effective Tax Rate
-1.44%0.00%0.00%131.69%-1.32%-0.43%
Updated May 20, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q